← Back to headlines
Roche Quarterly Sales Impacted by Blockbuster Eye Drug Performance
Roche's quarterly sales have been held back, primarily due to the performance of its blockbuster eye drug, affecting the company's overall financial results.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
